The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications
2
조회
0
다운로드
0
인용
0
참고문헌
초록
N6-methyladenosine (m6A) is one of the epigenetic modifications of RNA. The addition of this chemical mark to RNA molecules regulates gene expression by affecting the fate of the RNA molecules. This posttranscriptional RNA modification is reversible and regulated by methyltransferase “writers” and demethylase “erasers”. The fate of m6A-modified RNAs depends on the function of different “readers” that recognize and bind to them. Research on m6A methylation modification has recently increased due to its important role in regulating cancer progression. Noncoding RNAs (ncRNAs) are a class of RNA molecules that are transcribed from the genome but whose roles have been overlooked due to their lack of well-defined potential for translation into proteins or peptides. However, this misconception has now been completely overturned. ncRNAs regulate various diseases, especially tumors, and it has been confirmed that they play either tumor-promoting or tumor-suppressing roles in almost all types of tumors. In this review, we discuss the m6A modification of different types of ncRNA and summarize the mechanisms involved. Finally, we discuss the progress of research on clinical treatment and discuss the important significance of the m6A modification of ncRNAs in the clinical treatment of tumors.
Abstract
N6-methyladenosine (m6A) is one of the epigenetic modifications of RNA. The addition of this chemical mark to RNA molecules regulates gene expression by affecting the fate of the RNA molecules. This posttranscriptional RNA modification is reversible and regulated by methyltransferase “writers” and demethylase “erasers”. The fate of m6A-modified RNAs depends on the function of different “readers” that recognize and bind to them. Research on m6A methylation modification has recently increased due to its important role in regulating cancer progression. Noncoding RNAs (ncRNAs) are a class of RNA molecules that are transcribed from the genome but whose roles have been overlooked due to their lack of well-defined potential for translation into proteins or peptides. However, this misconception has now been completely overturned. ncRNAs regulate various diseases, especially tumors, and it has been confirmed that they play either tumor-promoting or tumor-suppressing roles in almost all types of tumors. In this review, we discuss the m6A modification of different types of ncRNA and summarize the mechanisms involved. Finally, we discuss the progress of research on clinical treatment and discuss the important significance of the m6A modification of ncRNAs in the clinical treatment of tumors.
참고문헌 (171)
- Zhang, H., "Dynamic landscape and evolution of m6A methylation in human", Nucleic Acids Res, 48, pp.6251~6264 (2020)
- Desrosiers, R., "Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells", Proc. Natl Acad. Sci. USA, 71, pp.3971~3975 (1974)
- Tan, B., "Viral and cellular N(6)-methyladenosine and N(6), 2’-O-dimethyladenosine epitranscriptomes in the KSHV life cycle", Nat. Microbiol, 3, pp.108~120 (2018)
- Schwartz, S., "High-resolution mapping reveals a conserved, widespread, dynamic mRNA methylation program in yeast meiosis", Cell, 155, pp.1409~1421 (2013)
- Zhong, S., "MTA is an Arabidopsis messenger RNA adenosine methylase and interacts with a homolog of a sex-specific splicing factor", Plant Cell, 20, pp.1278~1288 (2008)
- Zeng, C., "Roles of METTL3 in cancer : mechanisms and therapeutic targeting", J. Hematol. Oncol, 13, pp.117~ (2020)
- Liu, X., "Insights into roles of METTL14 in tumors", Cell Prolif, 55, pp.e13168~ (2021)
- Ping, X. L., "Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase", Cell Res, 24, pp.177~189 (2014)
- Lan, Q., "The critical role of RNA m(6)A methylation in cancer", Cell Res, 79, pp.1285~1292 (2019)
- Wang, T., "The potential role of RNA N6-methyladenosine in Cancer progression", Mol. Cancer, 19, pp.88~ (2020)
- Schwartz, S., "Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5’ sites", Cell Rep, 8, pp.284~296 (2014)
- Meyer, K. D., "Rethinking m(6)A readers, writers, and erasers", Annu. Rev. Cell Dev. Biol, 33, pp.319~342 (2017)
- Jia, G., "N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO", Nat. Chem. Biol, 7, pp.885~887 (2011)
- Zheng, G., "ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility", Mol. Cell, 49, pp.18~29 (2013)
- Chen, M., "The emerging roles of N6-methyladenosine (m6A)deregulation in liver carcinogenesis", Mol. Cancer, 19, pp.44~ (2020)
- Xu, Y., "YTH domain proteins : a family of m(6)A readers in cancer progression", Front. Oncol, 11, pp.629560~ (2021)
- Shi, H., "Where, when, and how : context-dependent functions of RNA methylation writers, readers, and erasers", Mol. Cell, 74, pp.640~650 (2019)
- Zhao, Y., "m(6)A-binding proteins : the emerging crucial performers in epigenetics", J. Hematol. Oncol, 13, pp.35~ (2020)
- Li, Y., "HNRNPL circularizes ARHGAP35 to produce an oncogenic protein", Adv. Sci, 8, pp.2001701~ (2021)
- Jin, D., "m(6)A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107", LATS2-mediated YAP activity in NSCLC, 2020, pp.19, 40~
- Alarcón, C. R., "HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events", Cell, 162, pp.1299~1308 (2015)
- Roundtree, I. A., "YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs", ELife, 6, pp.e31311~ (2017)
- Huang, H., "Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation", Nat. Cell Biol, 20, pp.285~295 (2018)
- Wang, X., "N(6)-methyladenosine modulates messenger RNA translation efficiency", Cell, 161, pp.1388~1399 (2015)
- Choi, J., "N(6)-methyladenosine in mRNA disrupts tRNA selection and translation-elongation dynamics", Nat. Struct. Mol. Biol, 23, pp.110~115 (2016)
- He, L., "Functions of N6-methyladenosine and its role in cancer", Mol. Cancer, 18, pp.176~ (2019)
- Treiber, T., "Regulation of microRNA biogenesis and its crosstalk with other cellular pathways", Nat. Rev. Mol. Cell Biol, 20, pp.5~20 (2019)
- Lee, J. T., "X-inactivation, imprinting, and long noncoding RNAs in health and disease", Cell, 152, pp.1308~1323 (2013)
- Böhmdorfer, G., "Control of chromatin structure by long noncoding RNA", Trends Cell Biol, 25, pp.623~632 (2015)
- Grossi, E., "A lncRNA-SWI", SNF complex crosstalk controls transcriptional activation at specific promoter regions, 2020, pp.11, 936~
- Shuman, S., "Transcriptional interference at tandem lncRNA and protein-coding genes : an emerging theme in regulation of cellular nutrient homeostasis", Nucleic Acids Res, 48, pp.8243~8254 (2020)
- Ransohoff, J. D., "The functions and unique features of long intergenic non-coding RNA", Nat. Rev. Mol. Cell Biol, 19, pp.143~157 (2018)
- Tay, Y., "The multilayered complexity of ceRNA crosstalk and competition", Nature, 505, pp.344~352 (2014)
- Chen, Y., "Interaction between N(6)-methyladenosine(m(6)A)modification and noncoding RNAs in cancer", Mol. Cancer, 19, pp.94~ (2020)
- Ma, S., "The interplay between m6A RNA methylation and noncoding RNA in cancer", J. Hematol. Oncol, 12, pp.121~ (2019)
- Coker, H., "m6A modification of non-coding RNA and the control of mammalian gene expression", Biochim. Biophys. Acta Gene Regul. Mech, 1862, pp.310~318 (2019)
- Huang, H., "m(6)A modification in coding and non-coding RNAs : roles and therapeutic implications in cancer", Cancer Cell, 37, pp.270~288 (2020)
- Yi, Y. C., "Novel insights into the interplay between m(6)A modification and noncoding RNAs in cancer", Mol. Cancer, 19, pp.121~ (2020)
- Oerum, S., "A comprehensive review of m6A", m6Am RNA methyltransferase structures, 2021, pp.49, 7239~7255
- Zuo, X., "M6A-mediated upregulation of LINC00958 increases lipogenesis and acts as a nanotherapeutic target in hepatocellular carcinoma", J. Hematol. Oncol, 13, pp.5~ (2020)
- Zheng, Y., "N6-methyladenosine modification of PTTG3P contributes to colorectal cancer proliferation via YAP1", Front. Oncol, 11, pp.669731~ (2021)
- Yin, H., "M6A RNA methylation-mediated RMRP stability renders proliferation and progression of non-small cell lung cancer through regulating TGFBR1", SMAD2, Cell Death Differ, pp.2021[DOI]
- Wu, Y., "m(6)A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1", Mol. Cancer, 18, pp.87~ (2019)
- Wang, J., "Long non-coding RNA RHPN1-AS1 promotes tumorigenesis and metastasis of ovarian cancer by acting as a ceRNA against miR-596 and upregulating LETM1", Aging, 12, pp.4558~4572 (2020)
- Tan, L., "N6-methyladenosine modification of LncRNA DUXAP9 promotes renal cancer cells proliferation and motility by activating the PI3K", AKT signaling pathway, 2021, pp.11, 641833~
- Rong, D., "m(6)A-induced LINC00958 promotes breast cancer tumorigenesis via the miR-378a-3p", YY1 axis, 2021, pp.7, 27~
- Qian, X., "LCAT3, a novel m6A-regulated long non-coding RNA, plays an oncogenic role in lung cancer via binding with FUBP1 to activate c-MYC", J. Hematol. Oncol, 14, pp.112~ (2021)
- Liu, H. T., "lncRNA THAP7-AS1, transcriptionally activated by SP1 and posttranscriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus", Cell Death Differ, 29, pp.627~641 (2021)
- Jia, G., "LNCAROD enhances hepatocellular carcinoma malignancy by activating glycolysis through induction of pyruvate kinase isoform PKM2", J. Exp. Clin. Cancer Res, 40, pp.299~ (2021)
- Ji, F., "m(6)A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer", Mol. Ther. Oncolytics, 22, pp.574~581 (2021)
- Iaiza, A., "METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors", Clin. Epigenetics, 13, pp.173~ (2021)
- Chen, J. Q., "M(6)A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p", VEGFA, Cell Cycle, pp.2021, 20[DOI]
- Chang, Y. Z., "METTL3 enhances the stability of MALAT1 with the assistance of HuR via m6A modification and activates NF-κB to promote the malignant progression of IDH-wildtype glioma", Cancer Lett, 511, pp.36~46 (2021)
- Liu, J., "METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1", c-Myc axis, 2022, pp.416, 113149~
- Kong, H., "Long intergenic non-protein coding RNA 1273 confers sorafenib resistance in hepatocellular carcinoma via regulation of methyltransferase 3", Bioengineered, 13, pp.3108~3121 (2022)
- Wu, J., "m6A-Induced LncRNA MEG3 Suppresses the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cell Through miR-544b", BTG2 Signaling, 2021, pp.14, 3745~3755
- Yang, Z., "ZFAS1 exerts an oncogenic role via suppressing miR-647 in an m(6)A-dependent manner in cervical cancer", Onco Targets Ther, 13, pp.11795~11806 (2020)
- Wen, S., "Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine", Mol. Cancer, 19, pp.171~ (2020)
- Wang, Z. W., "SRSF3-mediated regulation of N6-methyladenosine modification-related lncRNA ANRIL splicing promotes resistance of pancreatic cancer to gemcitabine", Cell Rep, 39, pp.110813~ (2022)
- Duan, J. L., "A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma", Mol. Cancer, 21, pp.93~ (2022)
- Xu, J., "N(6)-methyladenosine-modified CircRNA-SORE sustains sorafenib resistance in hepatocellular carcinoma by regulating β-catenin signaling", Mol. Cancer, 19, pp.163~ (2020)
- Wu, P., "N6-methyladenosine modification of circCUX1 confers radioresistance of hypopharyngeal squamous cell carcinoma through caspase1pathway", Cell Death Dis, 12, pp.298~ (2021)
- Chen, Z., "circ0000069 promotes cervical cancer cell proliferation and migration by inhibiting miR-4426", Biochem. Biophys. Res. Commun, 551, pp.114~120 (2021)
- Lin, C., "The N(6)-methyladenosine modification of circALG1 promotes the metastasis of colorectal cancer mediated by the miR-342-5p", PGF signalling pathway, 2022, pp.21, 80~
- Wang, T., "A novel protein encoded by circASK1 ameliorates gefitinib resistance in lung adenocarcinoma by competitively activating ASK1-dependent apoptosis", Cancer Lett, 520, pp.321~331 (2021)
- Rao, X., "N(6)-methyladenosine modification of circular RNA circ-ARL3facilitates Hepatitis B virus-associated hepatocellular carcinoma via sponging miR-1305", IUBMB Life, 73, pp.408~417 (2021)
- Chen, C., "N6-methyladenosine-induced circ1662 promotes metastasis of colorectal cancer by accelerating YAP1 nuclear localization", Theranostics, 11, pp.4298~4315 (2021)
- Liu, Z., "N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8(+)T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer", Mol. Cancer, 20, pp.105~ (2021)
- Rong, D., "m6A modification of circHPS5 and hepatocellular carcinoma progression through HMGA2 expression", Mol. Ther. Nucleic Acids, 26, pp.637~648 (2021)
- Zhang, J., "Excessive miR-25-3p maturation via N(6)-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression", Nat. Commun, 10, pp.1858~ (2019)
- Wang, H., "N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1", Mol. Cancer, 18, pp.181~ (2019)
- Liu, T., "Exosomal and intracellular miR-320b promotes lymphatic metastasis in esophageal squamous cell carcinoma", Mol. Ther. Oncolytics, 23, pp.163~180 (2021)
- Zhou, H., "The RNA m6A writer METTL14 in cancers : roles, structures, and applications", Biochim. Biophys. Acta Rev. Cancer, 1876, pp.188609~ (2021)
- Zheng, Z. Q., "Long noncoding RNA FAM225A promotes nasopharyngeal carcinoma tumorigenesis and metastasis by acting as ceRNA to Sponge miR-590-3p", miR-1275 and upregulate ITGB3, 2019, pp.79, 4612~4626
- Hu, N., "N6-methyladenosine(m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p", RAB19 axis, 2021, pp.12, 4081~4091
- Ban, Y., "LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma", Mol. Oncol, 14, pp.1282~1296 (2020)
- Mao, J., "LncRNA HCG11 mediated by METTL14 inhibits the growth of lung adenocarcinoma via IGF2BP2", LATS1, 2021, pp.580, 74~80
- Yang, X., "METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST", Mol. Cancer, 19, pp.46~ (2020)
- Peng, L., "Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1expression", Cell Biol. Toxicol, 38, pp.1159~1173 (2022)
- Liu, T., "Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1", Cancer Sci, 113, pp.446~458 (2022)
- Shen, D., "METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination", Mol. Ther. Nucleic Acids, 27, pp.547~561 (2022)
- Liu, Y., "LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma", J. Hematol. Oncol, 15, pp.52~ (2022)
- Fan, H. N., "METTL14-mediated m(6)A modification of circORC5 suppresses gastric cancer progression by regulating miR-30c-2-3p", AKT1S1 axis, 2022, pp.21, 51~
- Yi, D., "METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression", Oncol. Rep, 43, pp.1375~1386 (2020)
- An, L., "MicroRNA-211 attenuates cell proliferation in T-cell lymphoblastic lymphoma through targeting TCF12", Leuk. Res, 110, pp.106653~ (2021)
- Li, B., "circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity", Nat. Commun, 12, pp.295~ (2021)
- Schöller, E., "Interactions, localization, and phosphorylation of the m(6)A generating METTL3-METTL14-WTAP complex", RNA, 24, pp.499~512 (2018)
- Li, Z. X., "WTAP-mediated m(6)A modification of lncRNA DIAPH1-AS1enhances its stability to facilitate nasopharyngeal carcinoma growth and metastasis", Cell Death Differ, 29, pp.1137~1151 (2022)
- Ren, Z., "N(6)-methyladenosine methyltransferase WTAP-stabilized FOXD2-AS1 promotes the osteosarcoma progression through m(6)A", FOXM1 axis, 2022, pp.13, 7963~7973
- Huang, T., "N(6)-methyladenosine(m(6)A)-mediated lncRNA DLGAP1-AS1enhances breast canceradriamycin resistance through miR-299-3p", WTAP feedback loop, 2021, pp.12, 10935~10944
- Liu, H., "Circular RNA circDLC1 inhibits MMP1-mediated liver cancer progression via interaction with HuR", Theranostics, 11, pp.1396~1411 (2021)
- Knuckles, P., "Zc3h13", Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15, Fl(2)d, pp.Genes Dev, 2018[DOI]
- Jones, A. N., "Structural effects of m6A modification of the Xist A-repeat AUCG tetraloop and its recognition by YTHDC1", Nucleic Acids Res, 50, pp.2350~2362 (2022)
- Wang, X., "N(6)-methyladenosine modification of MALAT1 promotes metastasis via reshaping nuclear speckles", Dev. Cell, 56, pp.702~715 (2021)
- Ruszkowska, A., "METTL16, methyltransferase-like protein 16 : current insights into structure and function", Int. J. Mol. Sci, 22, pp.2176~ (2021)
- Brown, J. A., "Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix", Nat. Struct. Mol. Biol, 21, pp.633~640 (2014)
- Dai, Y. Z., "METTL16 promotes hepatocellular carcinoma progression through downregulating RAB11B-AS1 in an m(6)A-dependent manner", Cell Mol. Biol. Lett, 27, pp.41~ (2022)
- Zhang, X., "Structural insights into FTO’s catalytic mechanism for the demethylation of multiple RNA substrates", Proc. Natl Acad. Sci. USA, 116, pp.2919~2924 (2019)
- Cui, Y., "RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma", J. Exp. Clin. Cancer Res, 40, pp.294~ (2021)
- Wang, T., "FTO-stabilized lncRNA HOXC13-AS epigenetically upregulated FZD6 and activated Wnt", β-catenin signaling to drive cervical cancer proliferation, invasion, and EMT, 2021, pp.26, 1279~1291
- Bayoumi, M., "Structural insights into m6A-erasers : a step toward understanding molecule specificity and potential antiviral targeting", Front. Cell Dev. Biol, 8, pp.587108~ (2020)
- Guo, Y., "Circ3823 contributes to growth, metastasis and angiogenesis of colorectal cancer : involvement of miR-30c-5p", TCF7 axis, 2021, pp.20, 93~
- Dong, F., "ALKBH5 facilitates hypoxia-induced paraspeckle assembly and IL8 secretion to generate an immunosuppressive tumor microenvironment", Cell Res, 81, pp.5876~5888 (2021)
- Chen, S., "ALKBH5-mediated m(6)A demethylation of lncRNA PVT1 plays an oncogenic role in osteosarcoma", Cancer Cell Int, 20, pp.34~ (2020)
- He, Y., "ALKBH5 inhibits pancreatic cancer motility by decreasing long noncoding RNA KCNK15-AS1 methylation", Cell. Physiol. Biochem, 48, pp.838~846 (2018)
- Wu, S., "A novel micropeptide encoded by Y-linked LINC00278 links cigarette smoking and AR signaling in male esophageal squamous cell carcinoma", Cell Res, 80, pp.2790~2803 (2020)
- Zhang, J., "ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1", J. Physiol. Biochem, 75, pp.379~389 (2019)
- Yu, H., "ALKBH5-mediated m6A demethylation of lncRNA RMRP plays an oncogenic role in lung adenocarcinoma", Mamm. Genome, 32, pp.195~203 (2021)
- Guo, T., "ALKBH5 promotes colon cancer progression by decreasing methylation of the lncRNA NEAT1", Am. J. Transl. Res, 12, pp.4542~4549 (2020)
- Chen, Y., "Activation of YAP1 by N6-methyladenosine-modified circCPSF6drives malignancy in hepatocellular carcinoma", Cell Res, 82, pp.599~614 (2022)
- Song, W., "ALKBH5-mediated N(6)-methyladenosine modification of TRERNA1 promotes DLBCL proliferation via p21 downregulation", Cell Death Disco, 8, pp.25~ (2022)
- Wang, H., "m(6)A-seq analysis of microRNAs reveals that the N6-methyladenosine modification of miR-21-5p affects its target expression", Arch. Biochem. Biophys, 711, pp.109023~ (2021)
- Xu, C., "Structural basis for the discriminative recognition of N6-methyladenosine RNA by the human YT521-B homology domain family of proteins", J. Biol. Chem, 290, pp.24902~24913 (2015)
- Chen, Z., "The roles and mechanisms of the m6A reader protein YTHDF1 in tumor biology and human diseases", Mol. Ther. Nucleic Acids, 26, pp.1270~1279 (2021)
- Zhu, T., "Crystal structure of the YTH domain of YTHDF2 reveals mechanism for recognition of N6-methyladenosine", Cell Res, 24, pp.1493~1496 (2014)
- Arguello, A. E., "In vitro selection with a sitespecifically modified RNA library reveals the binding preferences of N(6)-methyladenosine reader proteins", Biochemistry, 58, pp.3386~3395 (2019)
- Li, Y., "ALKBH5-mediated m6A modification of lncRNA KCNQ1OT1 triggers the development of LSCC via upregulation of HOXA9", J. Cell. Mol. Med, 26, pp.385~398 (2022)
- Hu, Y., "A reciprocal feedback between N6-methyladenosine reader YTHDF3and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p", J. Exp. Clin. Cancer Res, 41, pp.69~ (2022)
- Shi, H., "YTHDF3 facilitates translation and decay of N(6)-methyladenosinemodified RNA", Cell Res, 27, pp.315~328 (2017)
- Chang, G., "YTHDF3 induces the translation of m(6)A-enriched gene transcripts to promote breast cancer brain metastasis", Cancer Cell, 38, pp.857~871 (2020)
- Ni, W., "Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m(6)A reader YTHDF3", Mol. Cancer, 18, pp.143~ (2019)
- Zhao, C., "The m6A methyltransferase METTL3controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1", miR-26b, Cancer Cell Int, pp.2021, 21[DOI]
- Wang, X., "N6-methyladenosine-dependent regulation of messenger RNA stability", Nature, 505, pp.117~120 (2014)
- Li, A., "Cytoplasmic m(6)A reader YTHDF3 promotes mRNA translation", Cell Res, 27, pp.444~447 (2017)
- Lasman, L., "Context-dependent functional compensation between Ythdf m(6)A reader proteins", Genes Dev, 34, pp.1373~1391 (2020)
- Zaccara, S., "A unified model for the function of YTHDF proteins in regulating m(6)A-modified mRNA", Cell, 181, pp.1582~1595 (2020)
- Li, Y., "Structural and dynamic insights into redundant function of YTHDF proteins", J. Chem. Inf. Model, 60, pp.5932~5935 (2020)
- Xu, C., "Structural basis for selective binding of m6A RNA by the YTHDC1YTH domain", Nat. Chem. Biol, 10, pp.927~929 (2014)
- Widagdo, J., "The multifaceted effects of YTHDC1-mediated nuclear m(6)A recognition", Trends Genet, 38, pp.325~332 (2022)
- Yang, L., "CircMET promotes tumor proliferation by enhancing CDKN2A mRNA decay and upregulating SMAD3", Mol. Cancer, 21, pp.23~ (2022)
- Ma, L., "The m(6)A reader YTHDC2 inhibits lung adenocarcinoma tumorigenesis by suppressing SLC7A11-dependent antioxidant function", Redox Biol, 38, pp.101801~ (2021)
- He, J. J., "m(6)A reader YTHDC2 promotes radiotherapy resistance of nasopharyngeal carcinoma via activating IGF1R", AKT, Front. Oncol, pp.2020, 10[DOI]
- Huang, X., "Insulin-like growth factor 2 mRNA-binding protein 1(IGF2BP1)in cancer", J. Hematol. Oncol, 11, pp.88~ (2018)
- Du, A., "M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma", Mol. Cancer, 21, pp.109~ (2022)
- Wang, J., "The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers", Cancer Cell Int, 21, pp.99~ (2021)
- Liu, H., "m(6)A reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability", Cell Death Disco, 7, pp.292~ (2021)
- Hu, X., "IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader", Cell Death Differ, 27, pp.1782~1794 (2020)
- Dong, L., "IGF2BP2 knockdown suppresses thyroid cancer progression by reducing the expression of long non-coding RNA HAGLR", Pathol. Res. Pract, 225, pp.153550~ (2021)
- Lu, S., "N6-methyladenosine reader IMP2 stabilizes the ZFAS1", OLA1 axis and activates the Warburg effect : implication in colorectal cancer, 2021, pp.14, 188~
- Han, L., "IGF2BP2 regulates MALAT1 by serving as an N6-methyladenosine reader to promote NSCLC proliferation", Front. Mol. Biosci, 8, pp.780089~ (2021)
- He, R. Z., "M6A modification of circNSUN2 promotes colorectal liver metastasis", Genes Dis, 8, pp.6~7 (2021)
- Bell, J. L., "Insulin-like growth factor 2 mRNA-binding proteins(IGF2BPs) : post-transcriptional drivers of cancer progression? Cell", Mol. Life Sci, 70, pp.2657~2675 (2013)
- Zhang, Y., "Long noncoding RNA KCNMB2-AS1 stabilized by N(6)-methyladenosine modification promotes cervical cancer growth through acting as a competing endogenous RNA", Cell Transpl, 29, pp.963689720964382~ (2020)
- Geuens, T., "The hnRNP family : insights into their role in health and disease", Hum. Genet, 135, pp.851~867 (2016)
- Rong, L., "HNRNPA2B1 inhibited SFRP2 and activated Wnt-β", catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma, 2022, pp.233, 153794~
- Lal, P., "Regulation of HuR structure and function by dihydrotanshinone-I", Nucleic Acids Res, 45, pp.9514~9527 (2017)
- Hou, P., "LINC00460", DHX9, J. Exp. Clin. Cancer Res, pp.2021, 40[DOI]
- Ye, M., "Oncogenic role of long noncoding RNAMALAT1 in thyroid cancer progression through regulation of the miR-204", IGF2BP2, Mol. Ther. Nucleic Acids, pp.2021, 23[DOI]
- Yang, D., "m(6)A transferase KIAA1429-stabilized LINC00958 accelerates gastric cancer aerobic glycolysis through targeting GLUT1", IUBMB Life, 73, pp.1325~1333 (2021)
- Christman, J. K., "5-Azacytidine and 5-aza-2’-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy", Oncogene, 21, pp.5483~5495 (2002)
- Stresemann, C., "Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine", Int. J. Cancer, 123, pp.8~13 (2008)
- Chen, B., "Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor", J. Am. Chem. Soc, 134, pp.17963~17971 (2012)
- Huang, Y., "Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5", Nucleic Acids Res, 43, pp.373~384 (2015)
- Su, R., "R-2HG Exhibits Anti-tumor Activity by Targeting FTO", m(6)A, CEBPA Signaling, pp.Cell, 2018[DOI]
- Shen, J., "N-methyladenosine reader YTHDF2-mediated long noncoding RNA FENDRR degradation promotes cell proliferation in endometrioid endometrial carcinoma", Lab. Invest, 101, pp.775~784 (2021)
- Wang, Y., "LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer", Mol. Cancer, 18, pp.174~ (2019)
- El Yacoubi, B., "Biosynthesis and function of posttranscriptional modifications of transfer RNAs", Annu. Rev. Genet, 46, pp.69~95 (2012)
- Sharma, S., "Identification of a novel methyltransferase, Bmt2, responsible for the N-1-methyl-adenosine base modification of 25S rRNA in Saccharomyces cerevisiae", Nucleic Acids Res, 41, pp.5428~5443 (2013)
- Dominissini, D., "The dynamic N(1)-methyladenosine methylome in eukaryotic messenger RNA", Nature, 530, pp.441~446 (2016)
- Li, X., "Base-resolution mapping reveals distinct m(1)A methylome in nuclearand mitochondrial-encoded transcripts", Mol. Cell, 68, pp.993~1005 (2017)
- Yang, X., "5-methylcytosine promotes mRNA export-NSUN2 as the methyltransferase and ALYREF as an m(5)C reader", Cell Res, 27, pp.606~625 (2017)
- Chen, X., "5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs", Nat. Cell Biol, 21, pp.978~990 (2019)
- Janin, M., "Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program", Acta Neuropathol, 138, pp.1053~1074 (2019)
- Ramanathan, A., "mRNA capping : biological functions and applications", Nucleic Acids Res, 44, pp.7511~7526 (2016)
- Sloan, K. E., "Tuning the ribosome : the influence of rRNA modification on eukaryotic ribosome biogenesis and function", RNA Biol, 14, pp.1138~1152 (2017)
- Tomikawa, C., "7-methylguanosine modifications in transfer RNA(tRNA)", Int. J. Mol. Sci, 19, pp.4080~ (2018)
- Pandolfini, L., "METTL1 promotes let-7 microRNA processing via m7G methylation", Mol. Cell, 74, pp.1278~1290 (2019)
- Chen, H., "METTL4 is an snRNA m(6)Am methyltransferase that regulates RNA splicing", Cell Res, 30, pp.544~547 (2020)
- Stern, L., "The role of the minor base N4-acetylcytidine in the function of the Escherichia coli noninitiator methionine transfer RNA", J. Biol. Chem, 253, pp.6132~6139 (1978)
- Sharma, S., "Yeast Kre33 and human NAT10 are conserved 18S rRNA cytosine acetyltransferases that modify tRNAs assisted by the adaptor Tan1", THUMPD1, 2015, pp.43, 2242~2258
- Dominissini, D., "N(4)-acetylation of cytidine in mRNA by NAT10regulates stability and translation", Cell, 175, pp.1725~1727 (2018)
